Nigel is a Versant Partner located in Basel where he plays a central role in the launch of future NewCos from Versant's Ridgeline Discovery Engine.

He is a seasoned pharma executive with extensive experience in Business Development, M&A and finance with large pharma companies across all stages of R&D and across therapy areas. Prior to joining Versant Nigel was Head of M&A and BD at Novartis.

Nigel was academically trained as a Molecuar Biologist and Chartered Accountant.